The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Yu Bin | - |
dc.contributor.author | Moon, Su-Jin | - |
dc.contributor.author | Jeon, Chan Hong | - |
dc.contributor.author | Song, Joon Young | - |
dc.contributor.author | Sung, Yoon-Kyoung | - |
dc.contributor.author | Jeong, Su Jin | - |
dc.contributor.author | Kwon, Ki Tae | - |
dc.contributor.author | Kim, Eu Suk | - |
dc.contributor.author | Kim, Jae-Hoon | - |
dc.contributor.author | Kim, Hyoun-Ah | - |
dc.contributor.author | Park, Dong-Jin | - |
dc.contributor.author | Park, Sung-Hoon | - |
dc.contributor.author | Park, Jin Kyun | - |
dc.contributor.author | Ahn, Joong Kyong | - |
dc.contributor.author | Oh, Ji Seon | - |
dc.contributor.author | Yun, Jae Won | - |
dc.contributor.author | Lee, Joo-Hyun | - |
dc.contributor.author | Lee, Hee Young | - |
dc.contributor.author | Choi, Min Joo | - |
dc.contributor.author | Choi, Won Suk | - |
dc.contributor.author | Choi, Young Hwa | - |
dc.contributor.author | Choi, Jung-Hyun | - |
dc.contributor.author | Heo, Jung Yeon | - |
dc.contributor.author | Cheong, Hee Jin | - |
dc.contributor.author | Lee, Shin-Seok | - |
dc.date.accessioned | 2021-09-10T06:50:04Z | - |
dc.date.available | 2021-09-10T06:50:04Z | - |
dc.date.issued | 2020-06 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.issn | 2092-6448 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/19516 | - |
dc.description.abstract | To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and the Korean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measles-mumps-rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults. | - |
dc.format.extent | 29 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy | - |
dc.title | The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3947/ic.2020.52.2.252 | - |
dc.identifier.scopusid | 2-s2.0-85091484822 | - |
dc.identifier.wosid | 000546188600017 | - |
dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.52, no.2, pp 252 - 280 | - |
dc.citation.title | Infection and Chemotherapy | - |
dc.citation.volume | 52 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 252 | - |
dc.citation.endPage | 280 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002603562 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | SYSTEMIC-LUPUS-ERYTHEMATOSUS | - |
dc.subject.keywordPlus | PNEUMOCOCCAL POLYSACCHARIDE VACCINE | - |
dc.subject.keywordPlus | NECROSIS FACTOR-ALPHA | - |
dc.subject.keywordPlus | HEALTH-CARE WORKERS | - |
dc.subject.keywordPlus | JUVENILE IDIOPATHIC ARTHRITIS | - |
dc.subject.keywordPlus | INFLUENZA A/H1N1 VACCINATION | - |
dc.subject.keywordPlus | LONG-TERM-CARE | - |
dc.subject.keywordPlus | ANTIBODY-RESPONSES | - |
dc.subject.keywordPlus | IMMUNE-RESPONSE | - |
dc.subject.keywordPlus | HERPES-ZOSTER | - |
dc.subject.keywordAuthor | Autoimmune inflammatory rheumatic disease | - |
dc.subject.keywordAuthor | Vaccine | - |
dc.subject.keywordAuthor | Immunization | - |
dc.subject.keywordAuthor | Guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.